127 related articles for article (PubMed ID: 33818835)
21. Treatment outcomes in veterans with HPV-positive head and neck cancer.
Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
[TBL] [Abstract][Full Text] [Related]
22. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy.
Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Gamez ME; Lukens JN; Shourbaji RA; Ryniak M; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
Anticancer Res; 2013 Dec; 33(12):5511-6. PubMed ID: 24324090
[TBL] [Abstract][Full Text] [Related]
24. Patterns of bone metastases from head and neck squamous cell carcinoma.
Suzuki A; Kashiwagi N; Doi H; Ishii K; Doi K; Kitano M; Kozuka T; Hyodo T; Tsurusaki M; Yagyu Y; Nakanishi K
Auris Nasus Larynx; 2020 Apr; 47(2):262-267. PubMed ID: 31445714
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
26. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
[TBL] [Abstract][Full Text] [Related]
27. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
28. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
29. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?
Wan XC; Egloff AM; Johnson J
Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow carcinosis in head and neck carcinoma in a young adult.
Frölich K; Alzoubi A; Müller J; Kleinsasser N
J Oral Maxillofac Surg; 2013 Apr; 71(4):e198-202. PubMed ID: 23351481
[TBL] [Abstract][Full Text] [Related]
31. A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma.
Saksø M; Andersen E; Bentzen J; Andersen M; Johansen J; Primdahl H; Overgaard J; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1495-1501. PubMed ID: 31519130
[No Abstract] [Full Text] [Related]
32. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
[TBL] [Abstract][Full Text] [Related]
33. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
[TBL] [Abstract][Full Text] [Related]
35. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
36. [Immunotherapy for head and neck squamous cell carcinoma].
Chen J; Chen M; Wu HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):143-147. PubMed ID: 28219181
[TBL] [Abstract][Full Text] [Related]
37. Regional control after concomitant chemoradiotherapy without planned neck dissection in node-positive head and neck squamous cell carcinomas.
Sakashita T; Homma A; Oridate N; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Auris Nasus Larynx; 2013 Apr; 40(2):211-5. PubMed ID: 22867524
[TBL] [Abstract][Full Text] [Related]
38. Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.
Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Saito T; Kawamori J; Tanaka Y; Hirotani Y; Homma T
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1221-1229. PubMed ID: 30756227
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
40. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
